Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for <i>Helicobacter pylori</i> in Chinese patients: an open label, randomised, crossover trial
Kevin S.H. Liu(Queen Mary Hospital), Wai K. Leung(Chinese University of Hong Kong), Ivan Fan‐Ngai Hung(Chinese University of Hong Kong), Siu‐Yin Wong(Queen Mary Hospital), Teresa Tong(University of Hong Kong), Wai‐Kay Seto(State Key Laboratory of Synthetic Chemistry), Axel Hsu(University of Hong Kong), David But(Queen Mary Hospital), Frank Y.F. Lam(Astellas Pharma (Japan))
Cited by 47
Related Papers
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis
|Gastroenterology|2020|1.7k
Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19
|Radiology|2020|1.5k
Screening for gastric cancer in Asia: current evidence and practice
|The Lancet Oncology|2008|830
Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing
|Clinical Infectious Diseases|2020|818
Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
|Clinical Infectious Diseases|2011|716